Immunocore Short Long Term Debt vs Total Assets Analysis

IMCR Stock

USD 60.23 0.77 1.29%

Immunocore Holdings financial indicator trend analysis is infinitely more than just investigating Immunocore Holdings recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunocore Holdings is a good investment. Please check the relationship between Immunocore Holdings Short Long Term Debt and its Total Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.

Short Long Term Debt vs Total Assets

Short Long Term Debt vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunocore Holdings Short Long Term Debt account and Total Assets. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Immunocore Holdings' Short Long Term Debt and Total Assets is -0.57. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Total Assets in the same time period over historical financial statements of Immunocore Holdings, assuming nothing else is changed. The correlation between historical values of Immunocore Holdings' Short Long Term Debt and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Immunocore Holdings are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Short Long Term Debt i.e., Immunocore Holdings' Short Long Term Debt and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.57

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Short Long Term Debt

The total of a company’s short-term and long-term borrowings.

Total Assets

Total assets refers to the total amount of Immunocore Holdings assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immunocore Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most indicators from Immunocore Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunocore Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.At this time, Immunocore Holdings' Tax Provision is relatively stable compared to the past year. As of 05/03/2024, Enterprise Value is likely to grow to about 3.5 T, while Selling General Administrative is likely to drop slightly above 84.5 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	47K	3.2M	4.1M	4.7M
Interest Income	47K	3.2M	12.5M	13.1M

Depreciation And Amortization Interest Income

Immunocore Holdings fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Net Receivables	Other Stockholder Equity	Total Current Assets	Property Plant Equipment	Other Current Assets	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Total Liab
Other Current Liab		0.59	-0.21	0.59	-0.77	-0.01	0.12	0.48	0.91	0.56	0.27	0.04	0.63	0.46	0.76	0.39	-0.77	0.59	0.55	0.54	0.5	0.59	-0.45	-0.26	0.49	0.77
Total Current Liabilities	0.59		-0.18	0.33	-0.85	0.54	0.32	0.91	0.8	0.75	0.8	0.5	0.85	0.9	0.73	0.81	-0.65	0.79	0.94	0.24	0.92	0.79	-0.71	-0.39	-0.01	0.87
Other Liab	-0.21	-0.18		-0.77	0.37	-0.39	-0.32	0.07	-0.3	-0.54	0.02	0.32	-0.53	-0.38	-0.59	-0.05	0.61	-0.58	-0.21	0.04	-0.37	-0.58	0.54	0.46	-0.47	-0.25
Net Tangible Assets	0.59	0.33	-0.77		-0.48	0.41	0.08	0.22	0.53	0.77	-0.12	-0.46	0.74	0.34	0.84	0.02	-0.9	0.76	0.25	0.3	0.36	0.76	-0.48	-0.46	0.79	0.5
Retained Earnings	-0.77	-0.85	0.37	-0.48		-0.41	-0.28	-0.69	-0.95	-0.66	-0.69	-0.42	-0.78	-0.89	-0.85	-0.73	0.77	-0.75	-0.85	-0.12	-0.9	-0.75	0.84	0.63	-0.14	-0.76
Accounts Payable	-0.01	0.54	-0.39	0.41	-0.41		0.33	0.64	0.26	0.57	0.46	0.1	0.61	0.64	0.6	0.37	-0.54	0.64	0.43	-0.11	0.63	0.64	-0.66	-0.72	0.14	0.24
Other Assets	0.12	0.32	-0.32	0.08	-0.28	0.33		0.31	0.2	0.17	0.42	0.06	0.29	0.29	0.26	0.2	-0.24	0.29	0.25	0.05	0.29	0.29	-0.28	-0.18	0.06	0.21
Net Receivables	0.48	0.91	0.07	0.22	-0.69	0.64	0.31		0.67	0.62	0.76	0.46	0.73	0.77	0.64	0.72	-0.56	0.67	0.8	0.3	0.78	0.67	-0.57	-0.39	-0.01	0.73
Other Stockholder Equity	0.91	0.8	-0.3	0.53	-0.95	0.26	0.2	0.67		0.63	0.59	0.33	0.74	0.77	0.85	0.68	-0.79	0.7	0.81	0.39	0.8	0.7	-0.72	-0.49	0.26	0.83
Total Current Assets	0.56	0.75	-0.54	0.77	-0.66	0.57	0.17	0.62	0.63		0.24	-0.14	0.98	0.66	0.85	0.32	-0.88	0.98	0.58	0.22	0.67	0.98	-0.66	-0.33	0.55	0.75
Property Plant Equipment	0.27	0.8	0.02	-0.12	-0.69	0.46	0.42	0.76	0.59	0.24		0.86	0.41	0.83	0.38	0.94	-0.22	0.34	0.88	0.06	0.83	0.34	-0.58	-0.44	-0.5	0.55
Other Current Assets	0.04	0.5	0.32	-0.46	-0.42	0.1	0.06	0.46	0.33	-0.14	0.86		0.0	0.55	-0.02	0.85	0.18	-0.08	0.68	-0.12	0.55	-0.08	-0.23	-0.23	-0.82	0.29
Total Assets	0.63	0.85	-0.53	0.74	-0.78	0.61	0.29	0.73	0.74	0.98	0.41	0.0		0.77	0.9	0.46	-0.9	0.99	0.7	0.25	0.78	0.99	-0.74	-0.42	0.46	0.82
Short Long Term Debt Total	0.46	0.9	-0.38	0.34	-0.89	0.64	0.29	0.77	0.77	0.66	0.83	0.55	0.77		0.74	0.85	-0.62	0.74	0.92	0.07	1.0	0.74	-0.9	-0.62	-0.08	0.69
Total Stockholder Equity	0.76	0.73	-0.59	0.84	-0.85	0.6	0.26	0.64	0.85	0.85	0.38	-0.02	0.9	0.74		0.45	-0.98	0.9	0.64	0.28	0.76	0.9	-0.79	-0.67	0.55	0.72
Property Plant And Equipment Net	0.39	0.81	-0.05	0.02	-0.73	0.37	0.2	0.72	0.68	0.32	0.94	0.85	0.46	0.85	0.45		-0.29	0.38	0.95	0.19	0.86	0.38	-0.55	-0.41	-0.46	0.69
Net Debt	-0.77	-0.65	0.61	-0.9	0.77	-0.54	-0.24	-0.56	-0.79	-0.88	-0.22	0.18	-0.9	-0.62	-0.98	-0.29		-0.91	-0.53	-0.3	-0.64	-0.91	0.71	0.58	-0.68	-0.69
Cash	0.59	0.79	-0.58	0.76	-0.75	0.64	0.29	0.67	0.7	0.98	0.34	-0.08	0.99	0.74	0.9	0.38	-0.91		0.63	0.17	0.75	1.0	-0.77	-0.46	0.52	0.73
Non Current Assets Total	0.55	0.94	-0.21	0.25	-0.85	0.43	0.25	0.8	0.81	0.58	0.88	0.68	0.7	0.92	0.64	0.95	-0.53	0.63		0.26	0.94	0.63	-0.68	-0.41	-0.21	0.84
Non Currrent Assets Other	0.54	0.24	0.04	0.3	-0.12	-0.11	0.05	0.3	0.39	0.22	0.06	-0.12	0.25	0.07	0.28	0.19	-0.3	0.17	0.26		0.1	0.17	0.04	0.25	0.34	0.55
Long Term Debt	0.5	0.92	-0.37	0.36	-0.9	0.63	0.29	0.78	0.8	0.67	0.83	0.55	0.78	1.0	0.76	0.86	-0.64	0.75	0.94	0.1		0.75	-0.88	-0.61	-0.06	0.73
Cash And Short Term Investments	0.59	0.79	-0.58	0.76	-0.75	0.64	0.29	0.67	0.7	0.98	0.34	-0.08	0.99	0.74	0.9	0.38	-0.91	1.0	0.63	0.17	0.75		-0.77	-0.46	0.52	0.73
Common Stock Shares Outstanding	-0.45	-0.71	0.54	-0.48	0.84	-0.66	-0.28	-0.57	-0.72	-0.66	-0.58	-0.23	-0.74	-0.9	-0.79	-0.55	0.71	-0.77	-0.68	0.04	-0.88	-0.77		0.73	-0.22	-0.48
Non Current Liabilities Total	-0.26	-0.39	0.46	-0.46	0.63	-0.72	-0.18	-0.39	-0.49	-0.33	-0.44	-0.23	-0.42	-0.62	-0.67	-0.41	0.58	-0.46	-0.41	0.25	-0.61	-0.46	0.73		-0.12	-0.13
Inventory	0.49	-0.01	-0.47	0.79	-0.14	0.14	0.06	-0.01	0.26	0.55	-0.5	-0.82	0.46	-0.08	0.55	-0.46	-0.68	0.52	-0.21	0.34	-0.06	0.52	-0.22	-0.12		0.18
Total Liab	0.77	0.87	-0.25	0.5	-0.76	0.24	0.21	0.73	0.83	0.75	0.55	0.29	0.82	0.69	0.72	0.69	-0.69	0.73	0.84	0.55	0.73	0.73	-0.48	-0.13	0.18

Click cells to compare fundamentals

Immunocore Holdings Account Relationship Matchups

Immunocore Holdings fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	5.1M	20.1M	39K	51K	114.3M	120.0M
Total Current Liabilities	84.5M	55.0M	61.2M	83.1M	139.0M	72.0M
Other Liab	48.1M	25.0M	6.5M	5.9M	5.3M	5.1M
Net Tangible Assets	14.8M	55.3M	171.5M	278.3M	320.1M	336.1M
Retained Earnings	(279.1M)	(349.9M)	(481.4M)	(261.3M)	(744.7M)	(707.4M)
Accounts Payable	15.7M	5.8M	35.4M	75.1M	17.8M	23.0M
Other Assets	6.5M	7.2M	7.5M	11.6M	10.4M	7.5M
Net Receivables	50.0M	23.2M	24.8M	58.4M	61.4M	40.2M
Other Stockholder Equity	293.9M	405.1M	266.6M	205.2M	1.1B	1.2B
Total Current Assets	124.3M	152.9M	262.7M	391.9M	528.8M	270.4M
Property Plant Equipment	54.9M	36.8M	31.5M	31.6M	36.4M	33.1M
Other Current Assets	48.8M	21.2M	18.8M	58.4K	9.7M	12.3M
Total Assets	185.6M	197.2M	301.8M	435.5M	597.0M	350.7M
Short Long Term Debt Total	59.4M	63.9M	63.8M	69.3M	84.0M	65.9M
Total Stockholder Equity	14.8M	55.3M	171.5M	278.8M	368.8M	387.3M
Property Plant And Equipment Net	54.9M	36.8M	31.5M	31.6M	42.7M	40.1M
Net Debt	(14.6M)	(65.8M)	(174.1M)	(263.2M)	(358.6M)	(340.7M)
Cash	74.0M	129.7M	237.9M	332.5M	442.6M	245.9M
Non Current Assets Total	61.4M	44.3M	39.0M	43.6M	68.2M	51.5M
Non Currrent Assets Other	4.4M	4.2M	(31.5M)	7.2M	14.5M	15.2M
Cash And Short Term Investments	74.0M	129.7M	237.9M	332.5M	442.6M	245.9M
Liabilities And Stockholders Equity	185.6M	197.2M	301.8M	435.5M	597.0M	350.7M
Non Current Liabilities Total	86.4M	86.9M	69.0M	73.7M	89.1M	66.0M
Capital Lease Obligations	40.3M	27.2M	26.6M	29.8M	36.0M	29.3M
Inventory	(48.6M)	(21.2M)	(18.8M)	943K	4.5M	4.7M
Total Liab	170.9M	141.8M	130.2M	156.8M	228.2M	177.3M
Net Invested Capital	33.9M	92M	208.8M	318.3M	416.9M	210.0M
Long Term Investments	591K	973K	165K	137K	123.3K	117.1K
Property Plant And Equipment Gross	54.9M	36.8M	31.5M	31.6M	95.0M	49.7M
Accumulated Other Comprehensive Income	(32K)	163K	386.3M	334.8M	(36.3M)	(34.4M)
Net Working Capital	39.8M	97.9M	201.5M	308.8M	389.8M	212.6M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunocore Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunocore Holdings' short interest history, or implied volatility extrapolated from Immunocore Holdings options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Immunocore Holdings is a strong investment it is important to analyze Immunocore Holdings' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Immunocore Holdings' future performance. For an informed investment choice regarding Immunocore Stock, refer to the following important reports:

How To Invest In Immunocore

Details

Is Immunocore Stock a good investment?

Details

What is Immunocore Holdings' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.

Note that the Immunocore Holdings information on this page should be used as a complementary analysis to other Immunocore Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Immunocore Stock analysis

When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.

	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites

Is Immunocore Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunocore Holdings. If investors know Immunocore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunocore Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.68)

Earnings Share

(1.41)

Revenue Per Share

5.102

Quarterly Revenue Growth

0.122

Return On Assets

(0.07)

The market value of Immunocore Holdings is measured differently than its book value, which is the value of Immunocore that is recorded on the company's balance sheet. Investors also form their own opinion of Immunocore Holdings' value that differs from its market value or its book value, called intrinsic value, which is Immunocore Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunocore Holdings' market value can be influenced by many factors that don't directly affect Immunocore Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Immunocore Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunocore Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunocore Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immunocore Short Long Term Debt vs Total Assets Analysis

Short Long Term Debt vs Total Assets

Short Long Term Debt vs Total Assets Correlation Analysis

Correlation Coefficient

Short Long Term Debt

Total Assets

Immunocore Holdings fundamental ratios Correlations

Immunocore Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immunocore Holdings fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Immunocore Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Assets	+ 0.98	Total Current Assets
Cash	+ 0.98	Total Current Assets

Net Debt	- 0.98	Total Stockholder Equity
Other Stockholder Equity	- 0.95	Retained Earnings
Cash And Short Term Investments	- 0.91	Net Debt
Cash	- 0.91	Net Debt
Common Stock Shares Outstanding	- 0.9	Short Long Term Debt Total
Net Debt	- 0.9	Total Assets